Reply  by Hägermark, Östen
0022-202X/8l/7702-0250$02_00/0 
TH E JOU Il NAL OF I NVESTIGATIV E O '; IlM ATOLOGV , 77:250-2:' 1,1 98 1 
Copyrighl © 1981 by The William" & Wil kins Co. 
LETTERS TO THE EDITOR 
Vol. 77, No.2 
Prilltcd ill U.S.A. 
We a re pleased to rece ive Lette rs to t he Editor on appropri ate s ubjects. These letters should be submitted 
in typewritten form , doubl e-spaced , a nd a re not to exceed 2'12 pages. When a ppropri a te, we will so licit com-
ments from t he origina l a u t hors. All Le tte rs to the Editor a re subject to editing a nd poss ible abridgment. 
Fd DEFICIENCY AND MOLECULAH S IZE OF SCLEHOMYX-
EDE MA MONOCLONAL IMM UNOG LOBULINS 
To the Editor: 
Recenlly (11. Fd deficiency of t he monoclona l IgG-lambda immuno-
globulin has been observed in a patient with scleromyxedema. The 
molecula r weigh t of t his pa raprotein was ))0,000 da ltons. This stimu -
lated us to perform s imilar investigations in 2 cases. After purification 
of t he monoclonal immunoglobulins (both IgGI -lambda) by isoelectric 
focus ing [2J these were subjected to immunoelectrophoresis with anti -
Fd and anti- Fab ant isera (Behrinbrwerke, Marburg, F.RG .) and ana lyt-
ical ultracentrifugation. No Fd deficiency could be detected by immu -
noelectrophoresis, t he molecula r weight of monomeric immunoglobu-
lins calculated from ul tracentrifugation was approx imately 160,000 
da ltons. These resul ts are in accordance with amino acid ana lysis of 
the monoclona l immunoglobulin of an early described case with papula r 
mucinosis, which d id not show subs tant ia l differences from norma l IgG 
[3]. Th e described Fd deficiency appears to be exceptiona l and may not 
explain t he obscure skin a bnormali ties. 
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REPLY · 
We do not cons ider the Fd defect to be the cause of scleromyxedema 
a lt hough in t he case reported by us demonstra ted such a defect. As it 
is d ifferent from 2 cases reported by Kovary et a l and fur ther it 
possesses a d ifferent monoclona l immunoglobulin (the i.r 2 cases dem -
onstrate ex istence of monoclonal irpmunoglobulin at IgG I posit ion while 
ou r case had monoclona l immunoglobulin at slow position) , no com-
- parison between them is possible but we would like to point out severa l 
problematic points iT;! methods. 
. l. It seems that Fd can not a lways be sepru·ated by the purification 
of immunoglobulins through isoeleclric focus ing. It is more desi.ra ble to 
examine t he reactions of a nti-Fd, a nt i-Fab and an ti-Fc aga inst immu -
noglobulin a fter purification as well as the dete rmining molecular 
weigh t using column chromatography. 
2. In the ir 2 cases existence of stereostructura l abnormality may be 
assumed even if normal IgG I a nd molecular weight a re ident ical; t hus 
it seems necessary to examine reactions with ant i-Fd; a nti -Fab a nd 
anti-Fe aga inst monoclonal immunoglobulin treated with mercaptoeth-
a nol a fter purification. 
3. Reactions with a nt i-Fd , anti-Fab and anti-Fc should a lso be 
examined after pos t purified monoclonal immunoglobu lin has been de-
composed by papain. 
S ince we do not know the details of their methodology, it is difficul t 
to comment fur ther on t he differences between these patients. 
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S UBSTAN CE P 
T o the 8ditor: 
Drs. H agermark, Hokfe lt , and Pernow (J Inves t Dermatol 71 :233-
235, 1978) desc ri be t he induction of fl a re a nd itch by in trade rmal 
inj ection of S ubstance P (SP) in human skin. While these au thors sta te 
that SP evoked fl ar e, wh eal, and itching at the injection s ite, nowhere 
do they describe any systemic effects of such intradermal injections. 
We recen t ly injected 0.05 ml of S P intraderma Uy into t he forearms of 
7 normal vo lun teers who had provided informed consent in concentra-
tions ranging from 6.2 X 10 7 M to 2 X 10- " M a nd were surprised by the 
sys tem ic reactions we observed in a ll subjects. At t he lowest concen tra-
tions we employed , gene ra lized flushing was noted within [) min of 
injection, and this flu shing pers is ted for a bout 10 min. At higher 
concent rations, this genera lized flushing was accompanied by ext raor-
dina ry injection of t he conjunctivae and sclerae, tachycardia, diapho-
resis, and was followed within 10 min by genera lized vasocons triction 
which lasted anothe r 10-20 min. Two subjects experienced mild wheez-
ing and t igh tness in their chests, as we ll as uncomfortable abdomina l 
se nsations. Unfortunate ly, because of the unexpected nature o f these 
systemic reactions , monitoring of cardiopulm onary status was ne-
glected. All subjects recovered fully within 30 min and none required 
specia l medical attention or cardiovascular drugs such as epinephrine. 
However, a ll who received the highest concen tration of SP employed, 
described the ir reaction as being among the most unpleasant they had 
ex pe rienced. Cons idering the exceedingly sma ll dosages employed in-
tradel·mally, one must be impressed by the potency of SP as a vasodi -
la ting agent. In ligh t of such poten t e ffec ts, inadver tan t in travenous 
in t roduction of such concen trations of SP cou ld prove fa ta l. We, t here-
fore, cau tion other investigators who have read Hagermark et al'~ 
a rti cle to exercise extreme ca ut ion in injecting human subjects with S1'. 
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REPLY 
Drs. Bernstein a nd Ha mill describe l5ystemic reactions with flushing, 
tachycardia, a nd other symptoms of vasodilation after intradermal 
injection of S ubstance P (SP) . We are as surprised as they to learn 
about t his, s ince we in no case observed any s ign whatsoeve r of systemic 
e ffects after th e SP injec tions a lthough we gave as much as 10 r. M . 
However, we did no t injec t more tha n 0.02 ml and a lways in t he upper 
a rms, while Drs. Berns tein and H am ill gave 0.05 ml and in t he forearms. 
S imila r reactions as t hose described by them have previous ly been 
found to occur in humans during intravenous infusion of 81' [1]. During 
infusion of 65 to 36G ng/ min (5 X 10 " _2.8 X 10- 111 moles/min) the 
subjects described feelings of warmth and sometimes experienced tem-
poral pulsations. At the same time a bright red flush was clearly seen 
in the head and nec k a nd in isolated spots on othe r pa rts of the body 
[Il Wi thin seconds a fte r stopping the infus ions the reactions disap-
peared, which contrasts in a remarkable way from the obse rvation of 
Drs. Bernstein a nd H a mill that the flushing pers isted for about .10 milT . 
They used SP from S igma, whi le the SP used in our s tudies was 
synthesized by Prof. K Folkers, Aus tin , T exas. 
It should be added tha t we a lways perform the ini t ia l experiments 
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on new substances ill ou r own skin. Recently we have injected other 
peptides in t raderma lly and found vasoactive in testinal polypeptide 
(V IP) as potent as SP [2'1. bu t in no case any sign of systemic reactions 
appeared. 
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B INDING OF BULLOUS PEMPHIGOID ANTIBODIES TO 
BASAL CELLS 
T o the Editor: 
Takeji Nishikawa a nd his associates repor t on the co-existence of 
autoantibodies to the basement membrane zone and the "basa l cell 
membrane a nd/or cytoplasm" in 8 of 12 sera from patients with bullous 
pemphigoid [11. On the basis of this observation and some blocking 
immunoflu orescence studies, the authors conclude that these represent 
2 types of pemphigoid antibodies and that the basal cell antibodies 
cross react wi th pemphigus ant ibodies. 
We do agree that basal ce ll a nt ibodies commonly co-exist with 
pemphigo id ant ibodies. Severa l li terature reports on the basal ce ll 
ant ibodies [21 indicate that they ru'e also found occasionally in the 
normal human sera a nd that they occur more commonly following 
t rauma to the skin; that is, in sera of patients who have suffe red severe 
burns, gra ft vs. host reactions, malignancies, drug reactions, pemphigus, 
and pemphigoid . These findings point to a lack of disease specificity of 
these antibodies which stands in contrast with the basement membrane 
zone antibodies of pemphigoid. Another difference between the basal 
cell ant ibodies and the basement membrane zone antibodies of pem-
phigoid is that the latter appear to bind to n.ormal skin in uiuo [3] whi le 
the basal ce ll ant ibodies fail to do so. 
Takeji Nishikawa and his associates give 2 alternate explanations for 
the localization of the basal cell ant ibodies, i. e. , "basement mem brane 
and/or cytoplasm." The picture of the indirect immunoflu orescence 
reaction patte rn of such basal ce ll antibodies as shown in the i.r Figure 
reveals unstained spaces between some of the basal cells, thus indicating 
that the reactive a ntigen(s) occur inside the cell at the periphery of the 
cytoplasm. This observation favors the second of the 2 alte rnate in ter-
pretations by T a keji Nishikawa et a t. ; t hey do not appear to be 
antibodies to the membranes of basal cells. This also affords a reason-
a ble explanation for the failure of these antibodies to bind in u£uo to 
their ant igen in normal skin. 
Considering the 3 a bove- listed di fferences between the basal ce ll 
ant ibodies and the basement membrane zone antibodies of pemphigoid, 
(notably the differences in their disease specificity, capacity to react in 
uiuo and histologic localization) we suggest an alternative explanation 
for the inte resting lindings of Takeji Nishikawa and his associates [1], 
notably that the re are 2 distinct, unrelated antibodies which do, as the 
authors state, frequently co-exist with basement membrane zone ant i-
bodies. We submit further that these 2 types of autoantibodies serve as 
examples of two distinct types of autoimmunity [4]. 
Another interesting finding of these authors is that pre-treatment of 
frozen tissue sections with sera containing the basal cell and basement 
membrane zone a ntibodies greatly reduced the staining by FITC la-
beled intercellular antibodies while pre-treatment with sera containing 
only basement membrane zone antibodies failed to do so [1]. T he 
authors interpret this to mean that there is some cross reactivity 
between pemphigus antibodies and bullous pemphigoid ant ibodies. 
Blocking immunofluorescence studies with FITC la beled pemphigus 
ant ibodies performed in this laboratory [5] showed that some normal 
human sera could block the 'binding of labeled pemphigus a ntibodies 
just as well as sera of pemphigus patients while the IgG fract ions of 
norma l sera fa iled to do so. Thus, immunoglobulin fractions, not whole 
sera, were deemed to be acceptable for blocking IF studies. T hese 
observations raise 2 in te resting questions a bout the blocking immuno-
tluol'escence s tudies of T a keji Nishikawa et a t. , notably: (1) if 20 or 
more normal sera were tested in such a b locking study, would they all 
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be negative? a nd (2) if the immunoglobulin fractions of sera with 
basement membrane zone ant ibodies wi th and without basal ce ll anti-
bodies were used for these blocking studies would they give the same 
re 'ul ts as the whole sera? T he lindings of Takej i Nishikawa and hi 
associates [ 11 clearly mer it further studies. 
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REPLY 
We are somewhat embru'l'assed to have the comments from Krasny 
et ai, because the in terpretation of our experimental results is com-
pletely different from the basic point [1]. Our interpretation is not the 
co-existence of 2 distinct a nt ibodies but quantitative difference of 
reactivity by basement membrane zone (BMZ) ant ibodies in pemphi-
goid sera. As far as we can understand from the staining pattern, there 
is a cont inuity of a ntigenic substance from the BMZ to the lower 
epidermal cells, as visualized by complement immunofluorescence only. 
Reg31'ding 2 questions a bout the blocking immunofluorescence stud-
ies, we, too, found most undilu ted normal human sera (NHS) could 
block the subsequent binding of FITC labeled inte rcellular antibodies 
(unpublished data). The same result could be obtained, when indirect 
immunofluorescent staining was applied to the skin substrate treated 
wi th undiluted NHS. However , NHS at 1:10 or more dilu t ions did not 
give any blocking of the subsequent staining of intercellular antibodies. 
We interprete this phenomenon as t he direct effect of undilu ted NHS 
[2] or the buffer [3] to the labile intercellular antigen(s) of the epider-
mis. We do not believe this experience of interceUul31' substance is 
applicable to the case of BMZ, since the antigenic property of in tercel-
lular substance and BMZ is lru'gely different. As shown in the Table III 
of our paper [1], the serum dilution of BP sera and that of the control 
NHS' was 1:10 d ilu t ion, where no such blocking effect of ·the serum to 
the skin substrate was shown. 
We obtained the most. purified IgG fraction from T.H. serum [1] by 
(NH., hSO., treatment and G-200 column chromatography and found 
that this purilied IgG at 7 units could block the subsequent binding of 
FITC labeled T .Y. at 2 un its. Al though more sera should be tested to 
draw the delini te conclusion, it seems as if our findings could be 
justified . 
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